<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: ASPO Session to Cover Sensorion Audiogene Trial of Pediatric Therapy for Hearing Loss	</title>
	<atom:link href="https://hearingreview.com/hearing-loss/patient-care/pediatric-care/aspo-session-to-cover-sensorion-audiogene-trial-of-pediatric-therapy-for-hearing-loss/feed" rel="self" type="application/rss+xml" />
	<link>https://hearingreview.com/hearing-loss/patient-care/pediatric-care/aspo-session-to-cover-sensorion-audiogene-trial-of-pediatric-therapy-for-hearing-loss</link>
	<description>Drawing on the content and resources of the two leading magazines in the hearing industry, The Hearing Review and Hearing Review Products is the single-stop web site for the hearing industry. It brings users the latest news, product developments, and legal and regulatory updates. Subjects include coverage of industry trends, developments in instruments, patient counseling, industry events and education.</description>
	<lastBuildDate>Mon, 28 Apr 2025 16:44:12 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.1</generator>
	<item>
		<title>
		By: Noel DCosta		</title>
		<link>https://hearingreview.com/hearing-loss/patient-care/pediatric-care/aspo-session-to-cover-sensorion-audiogene-trial-of-pediatric-therapy-for-hearing-loss/comment-page-1#comment-452668</link>

		<dc:creator><![CDATA[Noel DCosta]]></dc:creator>
		<pubDate>Sun, 27 Apr 2025 15:28:53 +0000</pubDate>
		<guid isPermaLink="false">https://hearingreview.com/?p=99087#comment-452668</guid>

					<description><![CDATA[Incredible progress. I remember meeting a family a few years ago whose baby was diagnosed with genetic hearing loss — they were told early intervention could change everything, but options were limited. Seeing trials like Audiogene and SENS-501 now gives real hope that future families won’t have to face the same uncertainty. Early treatment during brain plasticity could truly change lives.]]></description>
			<content:encoded><![CDATA[<p>Incredible progress. I remember meeting a family a few years ago whose baby was diagnosed with genetic hearing loss — they were told early intervention could change everything, but options were limited. Seeing trials like Audiogene and SENS-501 now gives real hope that future families won’t have to face the same uncertainty. Early treatment during brain plasticity could truly change lives.</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
